Home NDC 51407-172 Atazanavir Sulfate
Product NDC 51407-172
11-digit product format 514070172
Labeler code 51407
Product ID 51407-172_cecd8318-1a90-67f9-e053-2995a90afde4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Atazanavir Sulfate
Dosage form CAPSULE
Route ORAL
Labeler Golden State Medical Supply Inc.
Application ANDA091673
Marketing category ANDA
Marketing start 2017-12-27
Marketing end 0000-00-00
Substance ATAZANAVIR SULFATE
Active strength 200 mg/1
Pharmacologic classes HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 51407-172-60 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 51407-172-60 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 51407-172-60 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 51407-172-60 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 51407-172-60 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 51407-172-60 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 51407-172-60 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 51407-172-60 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 51407-172-60 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 51407-172-60 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 51407-172-60 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 51407-172-60 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091673-001 ATAZANAVIR SULFATE ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2014-04-22 A091673-002 ATAZANAVIR SULFATE ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2014-04-22 A091673-003 ATAZANAVIR SULFATE ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2014-04-22 A091673-004 ATAZANAVIR SULFATE ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2014-04-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A091673-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2014-04-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091673-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2014-04-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091673-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2014-04-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091673-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2014-04-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091673-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2014-04-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091673-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2014-04-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091673-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2014-04-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091673-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2014-04-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091673-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2014-04-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091673-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2014-04-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091673-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2014-04-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091673-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2014-04-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091673-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2014-04-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091673-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2014-04-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091673-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2014-04-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091673-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2014-04-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091673-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2014-04-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091673-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2014-04-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091673-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2014-04-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091673-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2014-04-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091673-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2014-04-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091673-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2014-04-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091673-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2014-04-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091673-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2014-04-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091673-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2014-04-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091673-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2014-04-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091673-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2014-04-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091673-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2014-04-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091673-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2014-04-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091673-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2014-04-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091673-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2014-04-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091673-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2014-04-22 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091673-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2014-04-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091673-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2014-04-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091673-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2014-04-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091673-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2014-04-22 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A091673-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2014-04-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091673-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2014-04-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091673-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2014-04-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091673-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2014-04-22 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 164 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 51407-172-60 51407017260 60 CAPSULE in 1 BOTTLE (51407-172-60) 60 capsule 2017-12-27 0000-00-00 No No Current